马尔他药品管理局（Malta Medicines Authority）邀请学术及科研界人士提交 Med-In Pharma 论文摘要，入选作品将纳入 Laparoscopic, Endoscopic and Robotics Society of Malta（LERSM）于 MedTech World Europe 2026 | Malta期间 ...
The United States is the world’s largest MedTech market. For any company with global ambitions, it is the market that matters most, and also one of the hardest to enter. From 5 to 7 May 2027, MedTech ...
Bioprosthetic heart valves have a limited lifespan and progressively degenerate over time, meaning that many patients will eventually require a second or third intervention. In aortic Valve-in-Valve ...
脑机介面（brain-computer interface, BCI）技术公司 Precision Neuroscience 宣布完成 2.5 亿美元的 D 轮融资。本轮融资超额认购，由 Pershing Square Inc.、Ackman Oxman Institute 及一家未公开名称的生命科学投资基金 ...
Members of the scientific community are invited by the Malta Medicines Authority to submit abstracts for Med-In Pharma, which will form part of the “Cutting Edge, Sustainable Futures” conference ...
Download the MedTech World Europe 2026 partnering platform and book your 1:1 meetings before arriving in Malta, 11–13 ...
The Cancer Research and Innovation Hub Malta (CRIHM) launches its national cancer awareness campaign with 685 people forming ...
Precision Neuroscience, a brain-computer interface (BCI) technology company, has raised $250 million in an oversubscribed Series D financing round co-led by Pershing Square Inc., the Ackman Oxman ...
Cordis’ SELUTION SLR sirolimus-eluting balloon receives FDA approval for treating coronary in-stent restenosis.
Guardant Health has received U.S. Food and Drug Administration (FDA) approval for Guardant360 CDx as a companion diagnostic to identify patients with hormone receptor (HR)-positive, HER2-negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results